Trusted Health announces $149M in funding for nurse work platform and other digital health fundings

Nursing startup Trusted Health introduced that it scored a whopping $149 million in funding. The funding breaks all the way down to $94 million from a Sequence C spherical led by Greenspring Associates and an unannounced $55 million Sequence B spherical that was led by Craft Ventures and Felicis Ventures. 

At the moment the San Francisco-based startup boasts a complete of $175 million in funding. The corporate has created a nurse staffing platform known as Works, which is targeted on filling nursing shifts. Trusted Well being lets employers create an on-demand workforce from inner and exterior sources in a single system. The system may help in predicting staffing calls for and in onboarding workers. 

This new infusion of money is anticipated to assist the corporate pace up the rollout of Works. 

“The pandemic exacerbated what we already knew: Healthcare staffing is in a disaster, and former makes an attempt to modernize the workforce have fallen quick. We’ve been left with a fragmented ecosystem of apps and companies for healthcare establishments attempting to resolve one drawback: matching the suitable clinician to the suitable position in essentially the most environment friendly method,” Trusted’s CEO and cofounder Lennie Silwinski stated in a press release.

“By means of a mix of know-how and shut working relationships with organizations like Mercy, we’ve constructed a platform that’s going to assist hospitals meet staffing challenges head-on to allow them to maintain their concentrate on delivering high quality affected person care.”


This morning RenalSense, an Israeli digital well being startup centered on renal diagnostics, scored $14 million in Sequence A funding. BlueRed Companions Fund led the spherical. 

The brand new funds will go in the direction of commercializing a product known as Readability RMS and dealing on the following technology of its sensor-platform-based merchandise. Readability RMS was designed to assist monitor sufferers in important care and detect any adjustments of their renal perform, in addition to their acute kidney damage danger. 

Trying down the highway, the corporate stated that it plans on creating extra sensor-based merchandise that may present diagnostic knowledge on the renewal system and different very important organ capabilities. 


Fertility-focused insurtech firm InsurMedix has raised $15 million, the primary portion of its $65 million funding spherical. A-Labs Advisory & Finance Ltd. led the spherical. 

The corporate has created an insurtech platform particularly for fertility. The platform, which is anticipated to launch in 2022, will supply insurance policies for fertility and IVF therapies. Members will even be capable of faucet into complementary and different drugs and outbound medical tourism. 

When the corporate launches, prospects within the U.S. will be capable of be a part of for a month-to-month subscription payment. 

“Our platform will supply all kinds of insurance coverage merchandise at extraordinarily inexpensive subscription costs, in a market that requires such merchandise for the previous many years, with no avail,” Darren Gradus, the corporate’s CEO, stated in a press release.

“We made it our prime goal to turn into the most important medical insurtech participant within the U.S. over the following 5 years, and we convey hope to those that can not afford these essential therapies.”

Leave a Reply